Molecular Diagnostics Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
Description
Persistence Market Research has recently released a comprehensive report on the worldwide market for molecular diagnostics. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.
Key Insights:
Molecular Diagnostics Market Size (2025E): USD 25.2 Billion
Projected Market Value (2032F): USD 43.4 Billion
Global Market Growth Rate (CAGR 2025 to 2032): 8.1%
Molecular Diagnostics Market - Report Scope:
Molecular diagnostics play a pivotal role in the identification of genetic mutations, detection of infectious agents, and assessment of disease predisposition, enabling early and precise disease diagnosis and management. This technology is extensively applied across fields such as oncology, infectious diseases, genetic testing, and blood screening. The molecular diagnostics market caters to hospitals, diagnostic laboratories, research institutions, and homecare settings, offering a wide range of technologies including PCR, next-generation sequencing (NGS), microarrays, and in situ hybridization. Market growth is driven by the rising burden of infectious and chronic diseases, increasing demand for personalized medicine, and rapid technological advancements that improve diagnostic accuracy, speed, and accessibility.
Market Growth Drivers:
The global molecular diagnostics market is propelled by several key factors, including the escalating demand for rapid and accurate diagnostic techniques to manage emerging infectious diseases such as COVID-19, HIV, and influenza. The increasing prevalence of cancer and genetic disorders has also accelerated the adoption of molecular tests for early detection and treatment planning. Moreover, the rise in the aging population, growing awareness about health and disease prevention, and favorable government initiatives promoting early disease screening contribute to market expansion. Technological innovations such as real-time PCR, automated workflows, and the integration of AI and machine learning in diagnostic platforms further boost market adoption and efficiency.
Market Restraints:
Despite the positive outlook, the molecular diagnostics market faces challenges such as high costs of instruments and reagents, particularly in low-resource settings. Stringent regulatory frameworks and lengthy approval processes for new diagnostic tests can delay market entry and limit product availability. Additionally, reimbursement limitations for certain molecular tests and a shortage of skilled professionals to operate sophisticated diagnostic equipment hinder broader adoption. Addressing these barriers requires coordinated efforts between industry stakeholders, governments, and healthcare providers to ensure affordable, accessible, and reliable diagnostic solutions across diverse healthcare systems.
Market Opportunities:
The molecular diagnostics market presents substantial opportunities driven by expanding applications in areas like pharmacogenomics, companion diagnostics, and prenatal testing. Growing demand for point-of-care molecular diagnostic devices and home-based testing kits offers avenues for reaching underserved populations and enhancing patient convenience. Increasing investment in R\&D and collaborations between biotech companies and academic institutions promote innovation and pipeline development. The ongoing digital transformation in healthcare, including the use of cloud-based data analysis platforms and remote diagnostics, opens new frontiers for personalized, real-time patient care. Companies investing in user-friendly, cost-effective, and scalable solutions stand to benefit significantly in this dynamic landscape.
Key Questions Answered in the Report:
What are the primary factors driving the growth of the molecular diagnostics market globally?
Which technologies and applications are driving molecular diagnostic adoption across different healthcare settings?
How are technological advancements reshaping the competitive landscape of the molecular diagnostics market?
Who are the key players contributing to the molecular diagnostics market, and what strategies are they employing to maintain market relevance?
What are the emerging trends and future prospects in the global molecular diagnostics market?
Competitive Intelligence and Business Strategy:
These companies are actively developing novel diagnostic assays, expanding their product portfolios to include multiplex and syndromic testing, and investing in automation and digital integration to enhance user experience. Partnerships with diagnostic labs, hospitals, and regulatory bodies support wider adoption and market access. Emphasis on clinical validation, regulatory compliance, and affordability helps address healthcare disparities and ensures sustainable growth in the evolving molecular diagnostics ecosystem.
Key Companies Profiled:
Becton, Dickinson and Company
Bio-Rad Laboratories In
Merck KgaA
Thermo Fisher Scientific Inc
Agilent Technologies, Inc.
F. Hoffman - La Roche Ltd.
Illumina, Inc.
Qiagen N.V.
Hologic Inc.
Siemens Healthineers AG
Seegene, Inc.
DiaSorin S.p.A
Grifols, S.A.
bioMérieux
QuidelOrtho Corporation
RapidBio
Abbott Laboratories
Danaher Corporation
Molecular Diagnostics Market Research Segmentation:
By Product Type:
Instruments
Consumables
By Disease Area:
Infectious Disease
Diabetes
Cardiology
Oncology
Nephrology
Autoimmune Disease
Dermatology
Wound Care
Others
By End-use:
Hospitals & Clinics
Diagnostics Laboratories
Academic and Research Institutes
Biopharmaceutical Companies
By Region:
North America
Europe
East Asia
South Asia & Oceania
Latin America
Middle East & Africa
Please Note: It will take 5 business days to complete the report upon order confirmation.
Key Insights:
Molecular Diagnostics Market Size (2025E): USD 25.2 Billion
Projected Market Value (2032F): USD 43.4 Billion
Global Market Growth Rate (CAGR 2025 to 2032): 8.1%
Molecular Diagnostics Market - Report Scope:
Molecular diagnostics play a pivotal role in the identification of genetic mutations, detection of infectious agents, and assessment of disease predisposition, enabling early and precise disease diagnosis and management. This technology is extensively applied across fields such as oncology, infectious diseases, genetic testing, and blood screening. The molecular diagnostics market caters to hospitals, diagnostic laboratories, research institutions, and homecare settings, offering a wide range of technologies including PCR, next-generation sequencing (NGS), microarrays, and in situ hybridization. Market growth is driven by the rising burden of infectious and chronic diseases, increasing demand for personalized medicine, and rapid technological advancements that improve diagnostic accuracy, speed, and accessibility.
Market Growth Drivers:
The global molecular diagnostics market is propelled by several key factors, including the escalating demand for rapid and accurate diagnostic techniques to manage emerging infectious diseases such as COVID-19, HIV, and influenza. The increasing prevalence of cancer and genetic disorders has also accelerated the adoption of molecular tests for early detection and treatment planning. Moreover, the rise in the aging population, growing awareness about health and disease prevention, and favorable government initiatives promoting early disease screening contribute to market expansion. Technological innovations such as real-time PCR, automated workflows, and the integration of AI and machine learning in diagnostic platforms further boost market adoption and efficiency.
Market Restraints:
Despite the positive outlook, the molecular diagnostics market faces challenges such as high costs of instruments and reagents, particularly in low-resource settings. Stringent regulatory frameworks and lengthy approval processes for new diagnostic tests can delay market entry and limit product availability. Additionally, reimbursement limitations for certain molecular tests and a shortage of skilled professionals to operate sophisticated diagnostic equipment hinder broader adoption. Addressing these barriers requires coordinated efforts between industry stakeholders, governments, and healthcare providers to ensure affordable, accessible, and reliable diagnostic solutions across diverse healthcare systems.
Market Opportunities:
The molecular diagnostics market presents substantial opportunities driven by expanding applications in areas like pharmacogenomics, companion diagnostics, and prenatal testing. Growing demand for point-of-care molecular diagnostic devices and home-based testing kits offers avenues for reaching underserved populations and enhancing patient convenience. Increasing investment in R\&D and collaborations between biotech companies and academic institutions promote innovation and pipeline development. The ongoing digital transformation in healthcare, including the use of cloud-based data analysis platforms and remote diagnostics, opens new frontiers for personalized, real-time patient care. Companies investing in user-friendly, cost-effective, and scalable solutions stand to benefit significantly in this dynamic landscape.
Key Questions Answered in the Report:
What are the primary factors driving the growth of the molecular diagnostics market globally?
Which technologies and applications are driving molecular diagnostic adoption across different healthcare settings?
How are technological advancements reshaping the competitive landscape of the molecular diagnostics market?
Who are the key players contributing to the molecular diagnostics market, and what strategies are they employing to maintain market relevance?
What are the emerging trends and future prospects in the global molecular diagnostics market?
Competitive Intelligence and Business Strategy:
These companies are actively developing novel diagnostic assays, expanding their product portfolios to include multiplex and syndromic testing, and investing in automation and digital integration to enhance user experience. Partnerships with diagnostic labs, hospitals, and regulatory bodies support wider adoption and market access. Emphasis on clinical validation, regulatory compliance, and affordability helps address healthcare disparities and ensures sustainable growth in the evolving molecular diagnostics ecosystem.
Key Companies Profiled:
Becton, Dickinson and Company
Bio-Rad Laboratories In
Merck KgaA
Thermo Fisher Scientific Inc
Agilent Technologies, Inc.
F. Hoffman - La Roche Ltd.
Illumina, Inc.
Qiagen N.V.
Hologic Inc.
Siemens Healthineers AG
Seegene, Inc.
DiaSorin S.p.A
Grifols, S.A.
bioMérieux
QuidelOrtho Corporation
RapidBio
Abbott Laboratories
Danaher Corporation
Molecular Diagnostics Market Research Segmentation:
By Product Type:
Instruments
- Polymerase Chain Reaction (PCR) Systems
- Hybridization (In-Situ Hybridization & Fish) Systems
- DNA Sequencing and Next-Generation Sequencing Platforms
- Microarrays
- Antibodies
- DNA Template
- DNA Polymerase
- Oligonucleotide Primers
- Deoxyribonucleotide Triphosphate (dNTPs)
- Buffer
Consumables
By Disease Area:
Infectious Disease
Diabetes
Cardiology
Oncology
Nephrology
Autoimmune Disease
Dermatology
Wound Care
Others
By End-use:
Hospitals & Clinics
Diagnostics Laboratories
Academic and Research Institutes
Biopharmaceutical Companies
By Region:
North America
Europe
East Asia
South Asia & Oceania
Latin America
Middle East & Africa
Please Note: It will take 5 business days to complete the report upon order confirmation.
Table of Contents
225 Pages
- 1. Executive Summary
- 1.1. Global Molecular Diagnostics Market Snapshot 2025 And 2032
- 1.2. Market Opportunity Assessment, 2025-2032, Us$ Bn
- 1.3. Key Market Trends
- 1.4. Industry Developments And Key Market Events
- 1.5. Demand Side And Supply Side Analysis
- 1.6. Pmr Analysis And Recommendations
- 2. Market Overview
- 2.1. Market Scope And Definitions
- 2.2. Value Chain Analysis
- 2.3. Macro-economic Factors
- 2.3.1. Global Gdp Outlook
- 2.3.2. Global Gdp Outlook
- 2.3.3. Global Economic Growth Forecast
- 2.3.4. Global Urbanization Growth
- 2.3.5. Other Macro-economic Factors
- 2.4. Forecast Factors – Relevance And Impact
- 2.5. Covid-19 Impact Assessment
- 2.6. Pestle Analysis
- 2.7. Porter's Five Forces Analysis
- 2.8. Geopolitical Tensions: Market Impact
- 2.9. Regulatory And Technology Landscape
- 3. Market Dynamics
- 3.1. Drivers
- 3.2. Restraints
- 3.3. Opportunities
- 3.4. Trends
- 4. Price Trend Analysis, 2019-2032
- 4.1. Region-wise Price Analysis
- 4.2. Price By Segments
- 4.3. Price Impact Factors
- 5. Global Molecular Diagnostics Market Outlook: Historical (2019-2024) And Forecast (2025-2032)
- 5.1. Key Highlights
- 5.2. Global Molecular Diagnostics Market Outlook: Product Type
- 5.2.1. Introduction/Key Findings
- 5.2.2. Historical Market Size (Us$ Bn) Analysis By Product Type, 2019-2024
- 5.2.3. Current Market Size (Us$ Bn) Forecast, By Product Type, 2025-2032
- 5.2.3.1. Instruments
- 5.2.3.1.1. Polymerase Chain Reaction (Pcr) Systems
- 5.2.3.1.2. Hybridization (In-situ Hybridization & Fish) Systems
- 5.2.3.1.3. Dna Sequencing And Next-generation Sequencing Platforms
- 5.2.3.1.4. Microarrays
- 5.2.3.2. Reagent
- 5.2.3.2.1. Antibodies
- 5.2.3.2.2. Dna Template
- 5.2.3.2.3. Dna Polymerase
- 5.2.3.2.4. Oligonucleotide Primers
- 5.2.3.2.5. Deoxyribonucleotide Triphosphate (Dntps)
- 5.2.3.2.6. Buffer
- 5.2.3.3. Assay Kits
- 5.2.3.4. Consumables
- 5.2.4. Market Attractiveness Analysis: Product Type
- 5.3. Global Molecular Diagnostics Market Outlook: Disease Area
- 5.3.1. Introduction/Key Findings
- 5.3.2. Historical Market Size (Us$ Bn) Analysis By Disease Area, 2019-2024
- 5.3.3. Current Market Size (Us$ Bn) Forecast, By Disease Area, 2025-2032
- 5.3.3.1. Infectious Disease
- 5.3.3.2. Diabetes
- 5.3.3.3. Cardiology
- 5.3.3.4. Oncology
- 5.3.3.5. Nephrology
- 5.3.3.6. Autoimmune Disease
- 5.3.3.7. Dermatology
- 5.3.3.8. Wound Care
- 5.3.3.9. Others
- 5.3.4. Market Attractiveness Analysis: Disease Area
- 5.4. Global Molecular Diagnostics Market Outlook: End-use
- 5.4.1. Introduction/Key Findings
- 5.4.2. Historical Market Size (Us$ Bn) Analysis By End-use, 2019-2024
- 5.4.3. Current Market Size (Us$ Bn) Forecast, By End-use, 2025-2032
- 5.4.3.1. Hospitals & Clinics
- 5.4.3.2. Diagnostics Laboratories
- 5.4.3.3. Academic And Research Institutes
- 5.4.3.4. Biopharmaceutical Companies
- 5.4.4. Market Attractiveness Analysis: End-use
- 6. Global Molecular Diagnostics Market Outlook: Region
- 6.1. Key Highlights
- 6.2. Historical Market Size (Us$ Bn) Analysis By Region, 2019-2024
- 6.3. Current Market Size (Us$ Bn) Forecast, By Region, 2025-2032
- 6.3.1. North America
- 6.3.2. Europe
- 6.3.3. East Asia
- 6.3.4. South Asia & Oceania
- 6.3.5. Latin America
- 6.3.6. Middle East & Africa
- 6.4. Market Attractiveness Analysis: Region
- 7. North America Molecular Diagnostics Market Outlook: Historical (2019-2024) And Forecast (2025-2032)
- 7.1. Key Highlights
- 7.2. Pricing Analysis
- 7.3. North America Market Size (Us$ Bn) Forecast, By Country, 2025-2032
- 7.3.1. U.S.
- 7.3.2. Canada
- 7.4. North America Market Size (Us$ Bn) Forecast, By Product Type, 2025-2032
- 7.4.1. Instruments
- 7.4.1.1. Polymerase Chain Reaction (Pcr) Systems
- 7.4.1.2. Hybridization (In-situ Hybridization & Fish) Systems
- 7.4.1.3. Dna Sequencing And Next-generation Sequencing Platforms
- 7.4.1.4. Microarrays
- 7.4.2. Reagent
- 7.4.2.1. Antibodies
- 7.4.2.2. Dna Template
- 7.4.2.3. Dna Polymerase
- 7.4.2.4. Oligonucleotide Primers
- 7.4.2.5. Deoxyribonucleotide Triphosphate (Dntps)
- 7.4.2.6. Buffer
- 7.4.3. Assay Kits
- 7.4.4. Consumables
- 7.5. North America Market Size (Us$ Bn) Forecast, By Disease Area, 2025-2032
- 7.5.1. Infectious Disease
- 7.5.2. Diabetes
- 7.5.3. Cardiology
- 7.5.4. Oncology
- 7.5.5. Nephrology
- 7.5.6. Autoimmune Disease
- 7.5.7. Dermatology
- 7.5.8. Wound Care
- 7.5.9. Others
- 7.6. North America Market Size (Us$ Bn) Forecast, By End-use, 2025-2032
- 7.6.1. Hospitals & Clinics
- 7.6.2. Diagnostics Laboratories
- 7.6.3. Academic And Research Institutes
- 7.6.4. Biopharmaceutical Companies
- 8. Europe Molecular Diagnostics Market Outlook: Historical (2019-2024) And Forecast (2025-2032)
- 8.1. Key Highlights
- 8.2. Pricing Analysis
- 8.3. Europe Market Size (Us$ Bn) Forecast, By Country, 2025-2032
- 8.3.1. Germany
- 8.3.2. Italy
- 8.3.3. France
- 8.3.4. U.K.
- 8.3.5. Spain
- 8.3.6. Russia
- 8.3.7. Rest Of Europe
- 8.4. Europe Market Size (Us$ Bn) Forecast, By Product Type, 2025-2032
- 8.4.1. Instruments
- 8.4.1.1. Polymerase Chain Reaction (Pcr) Systems
- 8.4.1.2. Hybridization (In-situ Hybridization & Fish) Systems
- 8.4.1.3. Dna Sequencing And Next-generation Sequencing Platforms
- 8.4.1.4. Microarrays
- 8.4.2. Reagent
- 8.4.2.1. Antibodies
- 8.4.2.2. Dna Template
- 8.4.2.3. Dna Polymerase
- 8.4.2.4. Oligonucleotide Primers
- 8.4.2.5. Deoxyribonucleotide Triphosphate (Dntps)
- 8.4.2.6. Buffer
- 8.4.3. Assay Kits
- 8.4.4. Consumables
- 8.5. Europe Market Size (Us$ Bn) Forecast, By Disease Area, 2025-2032
- 8.5.1. Infectious Disease
- 8.5.2. Diabetes
- 8.5.3. Cardiology
- 8.5.4. Oncology
- 8.5.5. Nephrology
- 8.5.6. Autoimmune Disease
- 8.5.7. Dermatology
- 8.5.8. Wound Care
- 8.5.9. Others
- 8.6. Europe Market Size (Us$ Bn) Forecast, By End-use, 2025-2032
- 8.6.1. Hospitals & Clinics
- 8.6.2. Diagnostics Laboratories
- 8.6.3. Academic And Research Institutes
- 8.6.4. Biopharmaceutical Companies
- 9. East Asia Molecular Diagnostics Market Outlook: Historical (2019-2024) And Forecast (2025-2032)
- 9.1. Key Highlights
- 9.2. Pricing Analysis
- 9.3. East Asia Market Size (Us$ Bn) Forecast, By Country, 2025-2032
- 9.3.1. China
- 9.3.2. Japan
- 9.3.3. South Korea
- 9.4. East Asia Market Size (Us$ Bn) Forecast, By Product Type, 2025-2032
- 9.4.1. Instruments
- 9.4.1.1. Polymerase Chain Reaction (Pcr) Systems
- 9.4.1.2. Hybridization (In-situ Hybridization & Fish) Systems
- 9.4.1.3. Dna Sequencing And Next-generation Sequencing Platforms
- 9.4.1.4. Microarrays
- 9.4.2. Reagent
- 9.4.2.1. Antibodies
- 9.4.2.2. Dna Template
- 9.4.2.3. Dna Polymerase
- 9.4.2.4. Oligonucleotide Primers
- 9.4.2.5. Deoxyribonucleotide Triphosphate (Dntps)
- 9.4.2.6. Buffer
- 9.4.3. Assay Kits
- 9.4.4. Consumables
- 9.5. East Asia Market Size (Us$ Bn) Forecast, By Disease Area, 2025-2032
- 9.5.1. Infectious Disease
- 9.5.2. Diabetes
- 9.5.3. Cardiology
- 9.5.4. Oncology
- 9.5.5. Nephrology
- 9.5.6. Autoimmune Disease
- 9.5.7. Dermatology
- 9.5.8. Wound Care
- 9.5.9. Others
- 9.6. East Asia Market Size (Us$ Bn) Forecast, By End-use, 2025-2032
- 9.6.1. Hospitals & Clinics
- 9.6.2. Diagnostics Laboratories
- 9.6.3. Academic And Research Institutes
- 9.6.4. Biopharmaceutical Companies
- 10. South Asia & Oceania Molecular Diagnostics Market Outlook: Historical (2019-2024) And Forecast (2025-2032)
- 10.1. Key Highlights
- 10.2. Pricing Analysis
- 10.3. South Asia & Oceania Market Size (Us$ Bn) Forecast, By Country, 2025-2032
- 10.3.1. India
- 10.3.2. Southeast Asia
- 10.3.3. Anz
- 10.3.4. Rest Of Sao
- 10.4. South Asia & Oceania Market Size (Us$ Bn) Forecast, By Product Type, 2025-2032
- 10.4.1. Instruments
- 10.4.1.1. Polymerase Chain Reaction (Pcr) Systems
- 10.4.1.2. Hybridization (In-situ Hybridization & Fish) Systems
- 10.4.1.3. Dna Sequencing And Next-generation Sequencing Platforms
- 10.4.1.4. Microarrays
- 10.4.2. Reagent
- 10.4.2.1. Antibodies
- 10.4.2.2. Dna Template
- 10.4.2.3. Dna Polymerase
- 10.4.2.4. Oligonucleotide Primers
- 10.4.2.5. Deoxyribonucleotide Triphosphate (Dntps)
- 10.4.2.6. Buffer
- 10.4.3. Assay Kits
- 10.4.4. Consumables
- 10.5. South Asia & Oceania Market Size (Us$ Bn) Forecast, By Disease Area, 2025-2032
- 10.5.1. Infectious Disease
- 10.5.2. Diabetes
- 10.5.3. Cardiology
- 10.5.4. Oncology
- 10.5.5. Nephrology
- 10.5.6. Autoimmune Disease
- 10.5.7. Dermatology
- 10.5.8. Wound Care
- 10.5.9. Others
- 10.6. South Asia & Oceania Market Size (Us$ Bn) Forecast, By End-use, 2025-2032
- 10.6.1. Hospitals & Clinics
- 10.6.2. Diagnostics Laboratories
- 10.6.3. Academic And Research Institutes
- 10.6.4. Biopharmaceutical Companies
- 11. Latin America Molecular Diagnostics Market Outlook: Historical (2019-2024) And Forecast (2025-2032)
- 11.1. Key Highlights
- 11.2. Pricing Analysis
- 11.3. Latin America Market Size (Us$ Bn) Forecast, By Country, 2025-2032
- 11.3.1. Brazil
- 11.3.2. Mexico
- 11.3.3. Rest Of Latam
- 11.4. Latin America Market Size (Us$ Bn) Forecast, By Product Type, 2025-2032
- 11.4.1. Instruments
- 11.4.1.1. Polymerase Chain Reaction (Pcr) Systems
- 11.4.1.2. Hybridization (In-situ Hybridization & Fish) Systems
- 11.4.1.3. Dna Sequencing And Next-generation Sequencing Platforms
- 11.4.1.4. Microarrays
- 11.4.2. Reagent
- 11.4.2.1. Antibodies
- 11.4.2.2. Dna Template
- 11.4.2.3. Dna Polymerase
- 11.4.2.4. Oligonucleotide Primers
- 11.4.2.5. Deoxyribonucleotide Triphosphate (Dntps)
- 11.4.2.6. Buffer
- 11.4.3. Assay Kits
- 11.4.4. Consumables
- 11.5. Latin America Market Size (Us$ Bn) Forecast, By Disease Area, 2025-2032
- 11.5.1. Infectious Disease
- 11.5.2. Diabetes
- 11.5.3. Cardiology
- 11.5.4. Oncology
- 11.5.5. Nephrology
- 11.5.6. Autoimmune Disease
- 11.5.7. Dermatology
- 11.5.8. Wound Care
- 11.5.9. Others
- 11.6. Latin America Market Size (Us$ Bn) Forecast, By End-use, 2025-2032
- 11.6.1. Hospitals & Clinics
- 11.6.2. Diagnostics Laboratories
- 11.6.3. Academic And Research Institutes
- 11.6.4. Biopharmaceutical Companies
- 12. Middle East & Africa Molecular Diagnostics Market Outlook: Historical (2019-2024) And Forecast (2025-2032)
- 12.1. Key Highlights
- 12.2. Pricing Analysis
- 12.3. Middle East & Africa Market Size (Us$ Bn) Forecast, By Country, 2025-2032
- 12.3.1. Gcc Countries
- 12.3.2. South Africa
- 12.3.3. Northern Africa
- 12.3.4. Rest Of Mea
- 12.4. Middle East & Africa Market Size (Us$ Bn) Forecast, By Product Type, 2025-2032
- 12.4.1. Instruments
- 12.4.1.1. Polymerase Chain Reaction (Pcr) Systems
- 12.4.1.2. Hybridization (In-situ Hybridization & Fish) Systems
- 12.4.1.3. Dna Sequencing And Next-generation Sequencing Platforms
- 12.4.1.4. Microarrays
- 12.4.2. Reagent
- 12.4.2.1. Antibodies
- 12.4.2.2. Dna Template
- 12.4.2.3. Dna Polymerase
- 12.4.2.4. Oligonucleotide Primers
- 12.4.2.5. Deoxyribonucleotide Triphosphate (Dntps)
- 12.4.2.6. Buffer
- 12.4.3. Assay Kits
- 12.4.4. Consumables
- 12.5. Middle East & Africa Market Size (Us$ Bn) Forecast, By Disease Area, 2025-2032
- 12.5.1. Infectious Disease
- 12.5.2. Diabetes
- 12.5.3. Cardiology
- 12.5.4. Oncology
- 12.5.5. Nephrology
- 12.5.6. Autoimmune Disease
- 12.5.7. Dermatology
- 12.5.8. Wound Care
- 12.5.9. Others
- 12.6. Middle East & Africa Market Size (Us$ Bn) Forecast, By End-use, 2025-2032
- 12.6.1. Hospitals & Clinics
- 12.6.2. Diagnostics Laboratories
- 12.6.3. Academic And Research Institutes
- 12.6.4. Biopharmaceutical Companies
- 13. Competition Landscape
- 13.1. Market Share Analysis, 2025
- 13.2. Market Structure
- 13.2.1. Competition Intensity Mapping
- 13.2.2. Competition Dashboard
- 13.3. Company Profiles
- 13.3.1. Becton, Dickinson And Company
- 13.3.1.1. Company Overview
- 13.3.1.2. Product Portfolio/Offerings
- 13.3.1.3. Key Financials
- 13.3.1.4. Swot Analysis
- 13.3.1.5. Company Strategy And Key Developments
- 13.3.2. Bio-rad Laboratories In
- 13.3.3. Merck Kgaa
- 13.3.4. Thermo Fisher Scientific Inc
- 13.3.5. Agilent Technologies, Inc.
- 13.3.6. F. Hoffman - La Roche Ltd.
- 13.3.7. Illumina, Inc.
- 13.3.8. Qiagen N.V.
- 13.3.9. Hologic Inc.
- 13.3.10. Siemens Healthineers Ag
- 13.3.11. Seegene, Inc.
- 13.3.12. Diasorin S.P.A
- 13.3.13. Grifols, S.A.
- 13.3.14. Biomérieux
- 13.3.15. Quidelortho Corporation
- 14. Appendix
- 14.1. Research Methodology
- 14.2. Research Assumptions
- 14.3. Acronyms And Abbreviations
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
